Business Description
Turnstone Biologics Corp
NAICS : 541715
SIC : 2833
ISIN : US90042W1009
Description
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which areĀ referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 29.49 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.16 | |||||
| Beneish M-Score | -4.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | 21.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.96 | |||||
| 9-Day RSI | 42.26 | |||||
| 14-Day RSI | 44.89 | |||||
| 6-1 Month Momentum % | 23.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.57 | |||||
| Quick Ratio | 8.57 | |||||
| Cash Ratio | 7.92 | |||||
| Days Sales Outstanding | 52.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 1.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -305.77 | |||||
| Net Margin % | -285.92 | |||||
| FCF Margin % | -349.12 | |||||
| ROA % | -52.46 | |||||
| ROIC % | -259.11 | |||||
| ROC (Joel Greenblatt) % | -477.98 | |||||
| ROCE % | -68.3 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.13 | |||||
| PB Ratio | 0.65 | |||||
| Price-to-Tangible-Book | 0.65 | |||||
| EV-to-EBIT | 0.41 | |||||
| EV-to-EBITDA | 0.44 | |||||
| EV-to-Revenue | -1.27 | |||||
| EV-to-FCF | 0.36 | |||||
| Price-to-Net-Current-Asset-Value | 0.72 | |||||
| Price-to-Net-Cash | 0.79 | |||||
| Earnings Yield (Greenblatt) % | 243.9 | |||||
| FCF Yield % | -105.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TSBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Turnstone Biologics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 19.306 | ||
| EPS (TTM) ($) | -2.678 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 44.89 | ||
| 14-Day ATR ($) | 0.371435 | ||
| 20-Day SMA ($) | 3.0195 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 1.625 - 13.2 | ||
| Shares Outstanding (Mil) | 23.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Turnstone Biologics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Turnstone Biologics Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Turnstone Biologics Corp Frequently Asked Questions
What is Turnstone Biologics Corp(TSBX)'s stock price today?
The current price of TSBX is $2.76. The 52 week high of TSBX is $13.20 and 52 week low is $1.63.
When is next earnings date of Turnstone Biologics Corp(TSBX)?
The next earnings date of Turnstone Biologics Corp(TSBX) is 2024-05-31 Est..
Does Turnstone Biologics Corp(TSBX) pay dividends? If so, how much?
Turnstone Biologics Corp(TSBX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers